John Mark Molot

Dr. John Mark Molot

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2021 in Reviews on Environmental Health
Verified
Journal Article
Open access
PDF file
JMJohn Mark Molot
John Mark Molot
MSMargaret Sears
Margaret Sears
LMLynn Margaret Marshall
Lynn Margaret Marshall
RBRiina I. Bray
Riina I. Bray
The World Health Organization lists air pollution as one of the top five risks for developing chronic non-communicable disease, joining tobacco use, harmful use of alcohol, unhealthy diets and physical inactivity. This review focuses on how host defense mechanisms against adverse airborne exposures relate to the probable interacting and overlapping pathophysiological features of neurodegeneration and multiple chemical sensitivity. Significant long-term airborne exposures can contribute to oxidative stress, systemic inflammation, transient receptor subfamily vanilloid 1 (TRPV1) and subfamily ankyrin 1 (TRPA1) upregulation and sensitization, with impacts on olfactory and trigeminal nerve function, and eventual loss of brain mass. The potential for neurologic dysfunction, including decreased cognition, chronic pain and central sensitization related to airborne contaminants, can be magnified by genetic polymorphisms that result in less effective detoxification. Onset of neurodegenerative disorders is subtle, with early loss of brain mass and loss of sense of smell. Onset of MCS may be gradual following long-term low dose airborne exposures, or acute following a recognizable exposure. Upregulation of chemosensitive TRPV1 and TRPA1 polymodal receptors has been observed in patients with neurodegeneration, and chemically sensitive individuals with asthma, migraine and MCS. In people with chemical sensitivity, these receptors are also sensitized, which is defined as a reduction in the threshold and an increase in the magnitude of a response to noxious stimulation. There is likely damage to the olfactory system in neurodegeneration and trigeminal nerve hypersensitivity in MCS, with different effects on olfactory processing. The associations of low vitamin D levels and protein kinase activity seen in neurodegeneration have not been studied in MCS. Table 2 presents a summary of neurodegeneration and MCS, comparing 16 distinctive genetic, pathophysiological and clinical features associated with air pollution exposures. There is significant overlap, suggesting potential comorbidity. Canadian Health Measures Survey data indicates an overlap between neurodegeneration and MCS (p < 0.05) that suggests comorbidity, but the extent of increased susceptibility to the other condition is not established. Nevertheless, the pathways to the development of these conditions likely involve TRPV1 and TRPA1 receptors, and so it is hypothesized that manifestation of neurodegeneration and/or MCS and possibly why there is divergence may be influenced by polymorphisms of these receptors, among other factors.

10 May 2023 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
JMJohn Mark Molot
John Mark Molot
MSMargaret Sears
Margaret Sears
HAHymie Anisman
Hymie Anisman
Multiple chemical sensitivity (MCS) is a complex medical condition associated with low dose chemical exposures. MCS is characterized by diverse features and common comorbidities, including fibromyalgia, cough hypersensitivity, asthma, and migraine, and stress/anxiety, with which the syndrome shares numerous neurobiological processes and altered functioning within diverse brain regions. Predictive factors linked to MCS comprise genetic influences, gene-environment interactions, oxidative stress, systemic inflammation, cell dysfunction, and psychosocial influences. The development of MCS may be attributed to the sensitization of transient receptor potential (TRP) receptors, notably TRPV1 and TRPA1. Capsaicin inhalation challenge studies demonstrated that TRPV1 sensitization is manifested in MCS, and functional brain imaging studies revealed that TRPV1 and TRPA1 agonists promote brain-region specific neuronal variations. Unfortunately, MCS has often been inappropriately viewed as stemming exclusively from psychological disturbances, which has fostered patients being stigmatized and ostracized, and often being denied accommodation for their disability. Evidence-based education is essential to provide appropriate support and advocacy. Greater recognition of receptor-mediated biological mechanisms should be incorporated in laws, and regulation of environmental exposures.

SRStephanie Robins
Stephanie Robins
JMJohn Mark Molot
John Mark Molot
RPRohini Lucy Peris
Rohini Lucy Peris
Multiple chemical sensitivity (MCS) describes an acquired condition characterized by recurrent, non-specific symptoms attributed to previously tolerated chemical exposure. Although Canada collects national data on MCS through population health surveys, the condition remains poorly understood and under-studied. This study analyzes data from the Canadian Community Health Survey (2000–2020) to examine trends in MCS prevalence across demographic characteristics, including province of residence, sex, and age. Descriptive analyses were used to assess temporal changes and differences between regions and population subgroups. Between 2000 and 2020, the proportion of Canadians reporting an MCS diagnosis increased from 1.9% to 3.5%. Prevalence varied geographically, with higher rates consistently observed in the Atlantic provinces compared with the Prairie provinces. MCS prevalence increased with age in both sexes; however, rates were higher among young males than females, with this pattern reversing in mid-life as prevalence became higher among females. These findings provide a national overview of MCS prevalence over two decades and offer relevant information for public health authorities, healthcare professionals, and researchers. The observed prevalence aligns with international estimates, underscoring MCS as an emerging public health concern in Canada.

17 July 2024 in JMIR Formative Research
Verified
Journal Article
Open access
RBRiina Bray
Riina Bray
YWYifan Wang
Yifan Wang
NANikolas Argiropoulos
Nikolas Argiropoulos
SRStephanie Robins
Stephanie Robins
JMJohn Mark Molot
John Mark Molot
RPRohini Lucy Peris
Rohini Lucy Peris
Background: Multiple chemical sensitivity (MCS) develops in response to repeated small-level chemical exposures or a major exposure in a subset of people, who then experience symptoms that can range from mild to debilitating when exposed to chemicals. The arrival of the COVID-19 pandemic and the stringent health measures put in place may have increased the burden for those living with MCS, as it became more challenging to avoid chemicals that trigger their condition. Objective: This study aimed to better understand the lived experience of Canadians living with MCS during the first year of the COVID-19 pandemic. Methods: An online questionnaire was created to ask participants to compare daily living during the pandemic to before March 11, 2020. Data were collected in January and February 2021. Three areas were investigated: (1) environmental exposures to chemical triggers from ambient air (pollution from industry, farming, and traffic) and indoor air (the smell of cleaning products, cooking odors, and smoke); (2) access to, and satisfaction with, health care visits; and (3) how people experiencing MCS rated contact with their social network. Results: In all, 119 Canadians who had lived with MCS for more than a year completed the questionnaire. The participant sample was mostly female (86.6%, n=103) and highly educated, with 57.1% (n=68) having a university degree. Slightly more than half (57.1%, n=68) were older than 55 years. McNemar chi-square and Wilcoxon signed rank tests were used to evaluate if there were statistically significant changes before (“prepandemic period”) and after (“postpandemic period”) March 11, 2020. Perceived exposure to pollution from a highway or a road was significantly decreased from the prepandemic to postpandemic period (z=–3.347; P<.001). Analysis of industry or power plants also suggested a significant decrease in the perceived exposure from the prepandemic to postpandemic period (z=–2.152; P=.04). Participants reported an increase in exposure to odors from disinfectants or sanitizers that entered their living environment (P<.001). There was a significant decrease between prepandemic and postpandemic levels of satisfaction when attending in-person meetings with a physician (z=–2.048; P=.04), yet there were no significant differences between prepandemic and postpandemic levels of satisfaction for online or telephone meetings with a physician. Although people with MCS experienced increased social isolation (P<.001), they also reported an increase in understanding from family (P=.03) and a decrease in stigma for wearing personal protective equipment (P<.001). Conclusions: During the first year of the COVID-19 pandemic, people with MCS were impacted by inaccessibility, loss of social support, and barriers to accessing health care. This study highlights unique challenges and possible benefits associated with the COVID-19 pandemic public health measures for individuals living with MCS. These findings can guide decision makers to improve policies on accessibility through appropriate accommodation measures.

9 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ATAdrianna Trifunovski
Adrianna Trifunovski
RLRoberto Lattanzio
Roberto Lattanzio
JMJohn Mark Molot
John Mark Molot
RBRiina Bray
Riina Bray
Caroline BarakatCaroline Barakat
Caroline Barakat
RPRohini Lucy Peris
Rohini Lucy Peris
Indoor air quality (IAQ) is an important determinant of public health, especially for individuals with multiple chemical sensitivity (MCS). Fragrances emit volatile organic compounds (VOCs) that can contribute to poor IAQ. Although scent-free policies are being widely implemented as an accommodation for those impacted by fragrances, their ability to improve IAQ has not been examined. This study assessed if scent-free policies can improve IAQ across Canadian offices. IAQ testing was conducted between December 2023 and June 2024 in 34 offices (17 with scent-free policies, 17 without). Sampling included total VOCs (TVOCs), top 35 VOCs, formaldehyde, CO, CO₂, PM₂.₅, temperature, and relative humidity. Analyses controlled for room size, occupancy, and ventilation rate using Mann-Whitney U tests and generalized linear models. Regression analysis revealed significantly higher VOC concentrations in spaces without scent-free policies, including acetaldehyde (OR = 2.2, p <.05), acetone (OR = 7.7, p <.001), toluene (OR = 3.4, p <0.05), m-/p-xylene (OR = 6.9, p <.001), o-Xylene (OR = 15.5, p <.001), and TVOCs (ORs = 3.9, p<.001). This study provides findings that support scent-free policies as a low-cost source control strategy to help lower VOC concentrations and improve IAQ accessibility.

14 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Nene Aïssatou DialloNene Aïssatou Diallo
Nene Aïssatou Diallo
JMJohn Mark Molot
John Mark Molot
RBRiina Bray
Riina Bray
ATAdrianna Trifunovski
Adrianna Trifunovski
RPRohini Lucy Peris
Rohini Lucy Peris
Multiple Chemical Sensitivity (MCS) is a chronic condition characterized by adverse reactions on exposure to low-level environmental chemical exposures, often resulting in multisystem symptoms triggered by substances such as volatile organic compounds (VOCs) from fragranced personal and household products. The condition emerges as public health and accessibility issues, as people with MCS may face barriers to accessing workplaces, healthcare settings, educational institutions, and other public environments. This study aims to describe the chemical exposures associated with the onset of the condition (sensitization) and subsequent symptom provocation in MCS, and to characterize symptom patterns and links with known transient receptor potential (TRP) receptor sensitization models. A cross-sectional survey was administered to Canadian residents aged 18 years or older, living with MCS for at least 1 year, with 18 questions assessing exposure history and associations with onset of MCS and symptom provocation. A total of 119 participants completed the survey. Condition onset often occurred at home (35%) and/or in the workplace (55%), following ongoing exposures (61%). Scents, such as perfumes and/or essential oils, including scented air fresheners, cleaning products, construction materials, disinfectants, and laundry products, were associated with both onset and subsequent symptom triggering. Symptoms involved multiple organ systems, with nearly one-third of participants reporting 11 or more symptoms. Cognitive and respiratory symptoms were most prevalent. Third-hand exposure may represent an underrecognized exposure pathway.